<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
83516-0107-1
</NDCCode>
<PackageDescription>
16700000 mg in 1 CONTAINER (83516-0107-1)
</PackageDescription>
<NDC11Code>
83516-0107-01
</NDC11Code>
<ProductNDC>
83516-0107
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Exenatide
</NonProprietaryName>
<DosageFormName>
POWDER
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20230131
</StartMarketingDate>
<EndMarketingDate>
20260630
</EndMarketingDate>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Resilience US, Inc.
</LabelerName>
<SubstanceName>
EXENATIDE
</SubstanceName>
<StrengthNumber>
5
</StrengthNumber>
<StrengthUnit>
mg/100mg
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-02-04
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
31-JAN-23
</StartMarketingDatePackage>
<EndMarketingDatePackage>
30-JUN-26
</EndMarketingDatePackage>
<SamplePackage/>
</NDC>